Trustee says Unigene Laboratories’ Chapter 7 case fully administered

By Caroline Salls

Pittsburgh, Aug. 3 – Unigene Laboratories, Inc.’s Chapter 7 estate has been fully administered, according to a notice filed Thursday in the U.S. Bankruptcy Court for the District of New Jersey by Chapter 7 trustee Nancy Isaacson.

Isaacson said $589,083 was distributed to Unigene creditors.

Administrative expenses totaled $478,359, and $33,250 in assets were abandoned.

The trustee said the liquidation of estate property yielded $1.07 million in net receipts.

Fairfield, N.J.-based Unigene is a biopharmaceutical company focusing on the oral and nasal delivery of large-market peptide drugs. The company filed bankruptcy on July 2, 2013 under Chapter 7 case number 13-24696.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.